0001415889-24-007182.txt : 20240307 0001415889-24-007182.hdr.sgml : 20240307 20240307162432 ACCESSION NUMBER: 0001415889-24-007182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Borgman Anne Elizabeth CENTRAL INDEX KEY: 0001886388 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38662 FILM NUMBER: 24730487 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD STREET 2: SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC. CENTRAL INDEX KEY: 0001382101 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452441988 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-392-8412 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: SUTRO BIOPHARMA INC DATE OF NAME CHANGE: 20061127 4 1 form4-03072024_090326.xml X0508 4 2024-03-05 0001382101 SUTRO BIOPHARMA, INC. STRO 0001886388 Borgman Anne Elizabeth C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF MEDICAL OFFICER 0 Stock Option (Right to Buy Common Stock) 4.54 2024-03-05 4 A 0 60000 0 A 2034-03-05 Common Stock 60000 60000 D Restricted Stock Units (RSUs) 2024-03-05 4 A 0 45000 0 A 2028-03-01 Common Stock 45000 45000 D The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date. Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date. /s/ Edward C. Albini as attorney-in-fact for Anne E. Borgman 2024-03-07